COTINGA PHARMACEUTICALS INC. ("COT")
BULLETIN TYPE: Private Placement-Brokered-Non-Brokered
BULLETIN DATE: May 15, 2018
TSX Venture Tier 2 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Brokered and Non-Brokered Private Placement announced May 4, 2018:
Number of Shares: 5,289,900 common shares
Purchase Price: $0.38 per share
Warrants: 5,289,900 share purchase warrants attached to purchase 5,289,900 shares
Warrant Exercise Price: $0.47 for a five year period
Number of Placees: 20 Placees
Insider / Pro Group Participation:
Insider=Y /
Name ProGroup=P # of Shares
John Drake Y 131,500
Douglas Alexander Y 20,000
Gene Kelly Y 40,100
Dr. John Yoo Medicine Professional Corp. Y 13,200
Richard Theodore Ho Y 76,300
Alison Silva Y 62,800
Agent/Finder's Fee: Aggregate cash commissions of $100,035 and 185,697 broker/finders' warrants issued to Roth Capital Partners, LLC, Industrial Alliance Securities Inc. and CIBC World Markets Inc. Each broker/finder's warrant entitles the holder to acquire one common share at $0.47 for a five year period.
The Company has issued a new release announcing the closing of the private placement and setting out the expiry dates of the hold period(s).
________________________________________
|
|
